Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry

Sci Rep. 2015 Mar 4:5:8759. doi: 10.1038/srep08759.

Abstract

Immunoaffinity enrichment of proteotypic peptides, coupled with selected reaction monitoring, enables indirect protein quantification. However the lack of suitable antibodies limits its widespread application. We developed a method in which multi-specific antibodies are used to enrich groups of peptides, thus facilitating multiplexed quantitative protein assays. We tested this strategy in a pharmacokinetic experiment by targeting a group of homologous drug transforming proteins in human hepatocytes. Our results indicate the generic applicability of this method to any biological system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / immunology
  • ATP Binding Cassette Transporter, Subfamily B / metabolism
  • Amino Acid Sequence
  • Antibodies / immunology
  • Antibody Affinity
  • Aryl Hydrocarbon Hydroxylases / immunology
  • Aryl Hydrocarbon Hydroxylases / metabolism
  • Atorvastatin / pharmacokinetics
  • Cells, Cultured
  • Chromatography, Liquid / methods
  • Cytochrome P-450 CYP3A / immunology
  • Cytochrome P-450 CYP3A / metabolism
  • Epitopes / immunology
  • Epitopes / metabolism
  • Hepatocytes / cytology
  • Hepatocytes / enzymology*
  • Hepatocytes / metabolism*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacokinetics
  • Mass Spectrometry / methods*
  • Peptides / immunology
  • Peptides / metabolism*
  • Pravastatin / pharmacokinetics
  • Primary Cell Culture
  • Sequence Homology, Amino Acid

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • Antibodies
  • Epitopes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Peptides
  • Atorvastatin
  • Aryl Hydrocarbon Hydroxylases
  • CYP3A7 protein, human
  • Cytochrome P-450 CYP3A
  • Pravastatin